Nexgel (NXGLW) Cost of Revenue (2018 - 2025)
Nexgel's Cost of Revenue history spans 8 years, with the latest figure at $2.0 million for Q4 2025.
- For Q4 2025, Cost of Revenue rose 0.51% year-over-year to $2.0 million; the TTM value through Dec 2025 reached $6.9 million, up 15.1%, while the annual FY2025 figure was $6.9 million, 16.36% up from the prior year.
- Cost of Revenue reached $2.0 million in Q4 2025 per NXGLW's latest filing, up from $1.7 million in the prior quarter.
- In the past five years, Cost of Revenue ranged from a high of $2.0 million in Q4 2025 to a low of $309000.0 in Q1 2021.
- Average Cost of Revenue over 5 years is $998100.0, with a median of $934500.0 recorded in 2023.
- Peak YoY movement for Cost of Revenue: soared 139.55% in 2023, then fell 5.27% in 2025.
- A 5-year view of Cost of Revenue shows it stood at $430000.0 in 2021, then rose by 13.49% to $488000.0 in 2022, then surged by 139.55% to $1.2 million in 2023, then soared by 68.26% to $2.0 million in 2024, then grew by 0.51% to $2.0 million in 2025.
- Per Business Quant, the three most recent readings for NXGLW's Cost of Revenue are $2.0 million (Q4 2025), $1.7 million (Q3 2025), and $1.6 million (Q2 2025).